VYYRF (Voyageur Pharmaceuticals) OCF Margin %: -864.29% (As of Feb. 2026)


VYYRF Voyageur Pharmaceuticals Ltd VYYRF
18 GF Score
Price $0.10
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals OCF Margin %?

Voyageur Pharmaceuticals VYYRF +7.71% 18 OCF Margin % is -864.29% as of Feb. 2026. GuruFocus rates VYYRF with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 956 Drug Manufacturers companies, Voyageur Pharmaceuticals ranks worse than 99.06% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Voyageur Pharmaceuticals's Cash Flow from Operations for the three months ended in Feb. 2026 was $-0.12 Mil. Voyageur Pharmaceuticals's Revenue for the three months ended in Feb. 2026 was $0.01 Mil. Therefore, Voyageur Pharmaceuticals's OCF Margin % for the quarter that ended in Feb. 2026 was -864.29%.

As of today, Voyageur Pharmaceuticals's current OCF Yield % is -7.71%.

The historical rank and industry rank for Voyageur Pharmaceuticals's OCF Margin % or its related term are showing as below:

VYYRF' s OCF Margin % Range Over the Past 10 Years
Min: -24108.33   Med: -24108.33   Max: -24108.33
Current: -6369.57

During the past 13 years, the highest OCF Margin % of Voyageur Pharmaceuticals was -24108.33%. The lowest was -24108.33%. And the median was -24108.33%.

VYYRF's OCF Margin % is ranked worse than
99.06% of 956 companies
in the Drug Manufacturers industry
Industry Median: 9.985 vs VYYRF: -6369.57

Voyageur Pharmaceuticals OCF Margin % Related Terms

Voyageur Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Voyageur Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals OCF Margin % Chart

Voyageur Pharmaceuticals Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -22,866.67

Voyageur Pharmaceuticals Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -8,000.00 -26,300.00 -864.29

VYYRF vs ZTS, UTHR: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Voyageur Pharmaceuticals OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's OCF Margin % falls into.


VYYRF
18GF Score
Voyageur Pharmaceuticals Ltd VYYRF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Voyageur Pharmaceuticals's OCF Margin for the fiscal year that ended in Nov. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Nov. 2025 )/Revenue (A: Nov. 2025 )
=-2.058/0.009
=-22,866.67 %

Voyageur Pharmaceuticals's OCF Margin for the quarter that ended in Feb. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.121/0.014
=-864.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -864.29% mean?
Voyageur Pharmaceuticals (VYYRF) has a OCF Margin % of -864.29% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Voyageur Pharmaceuticals and its competitors. According to the industry distribution chart, Voyageur Pharmaceuticals ranks #947 out of 956 companies in the Drug Manufacturers industry, placing it in the top 99.1%.
Is Voyageur Pharmaceuticals' OCF Margin % too high?
Voyageur Pharmaceuticals' current OCF Margin % is -864.29%. Based on the distribution chart, Voyageur Pharmaceuticals ranks #947 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Voyageur Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Voyageur Pharmaceuticals ranks #947 out of 956 companies for OCF Margin %. This places Voyageur Pharmaceuticals in the lower half of its industry. The industry median OCF Margin % is 9.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Voyageur Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Voyageur Pharmaceuticals's current OCF Margin % is -864.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current OCF Margin % of -864.29%. The current OCF Margin % is -864.29%. Voyageur Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current OCF Margin % is -864.29% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
18GF Score

Get the complete analysis for VYYRF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price